What is Lemonade, Inc.'s earnings per share (EPS)?

Lemonade, Inc. (LMND) reported diluted earnings per share of -$2.24 for fiscal year 2025. This represents a 21.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lemonade, Inc. (LMND) Financials

LMND

Trailing 12 months to June 30, 2026

Revenue $975.0M +62.3% YoY

Net Income -$138.9M +31.9% YoY

EPS (Diluted) -$1.82 +35.5% YoY

Free Cash Flow $8.1M +137.9% YoY

Market Cap $3.6B as of Oct 10, 2026

Price / Sales 3.7x on $975.0M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 7.2x on $499.5M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LMND SEC filings page.

Lemonade, Inc. (LMND) reported $975.0M in revenue over the twelve months to Jun 30, 2026, up 62.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LMND FY2025 2026-10-03

Revenue is scaling quickly, but persistent losses and rising leverage show growth still relies on financing beyond operating cash.

Liabilities rose from $1.26B to $1.39B while equity fell from $593.4M to $533.6M, making the balance sheet increasingly dependent on creditors. The debt-to-equity ratio consequently climbed from 2.1x to 2.6x, alongside $106.6M of financing cash flow in FY2025, indicating expansion was not funded solely by operations.

Revenue reached $737.9M in FY2025, while the net margin improved from -38.4% to -22.5%; losses are shrinking faster than sales are expanding, but profitability has not yet arrived. The improvement points to better operating economics without proving whether mix, pricing, or cost structure drove it.

Net loss was $166M while operating cash flow was -$16.5M, so accounting losses substantially exceeded cash consumption. However, free cash flow remained -$25.9M after capital spending, showing that near-break-even operating cash flow still did not produce cash retention.

Financial Health Signals

Financial Health Score 48/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Lemonade, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Lemonade, Inc. scores 23/100 on it among other insurers.

Premium Growth

Lemonade, Inc. reported revenue of $737.9M in fiscal year 2025, against $526.5M in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Lemonade, Inc. scores 96/100 among other insurers.

Capital

Lemonade, Inc. funded 27.7% of its assets with shareholders' equity at the end of fiscal year 2025, holding $533.6M of equity against $1.9B of assets. Capital ranks insurers on that cushion, and Lemonade, Inc. scores 64/100 among other insurers.

Investment Yield

Not available for Lemonade, Inc., and counted as zero in the overall score.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Lemonade, Inc. scores 13/100 on it among other insurers.

Stability

Lemonade, Inc. reported a net loss of $166.0M in fiscal year 2025, against a loss of $202.2M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Lemonade, Inc. scores 90/100 among other insurers.

Piotroski F-Score Partial

3/6

Lemonade, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Lemonade, Inc. reported a net loss of $166.0M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$294.4M

YoY+79.4%

QoQ+14.1%

5Y CAGR+59.9%

Lemonade, Inc. generated $294.4M in revenue in Q2 2026. This represents an increase of 79.4% from the same quarter a year earlier. Against the prior quarter it is up 14.1%.

Net Income

-$43.4M

YoY+1.1%

QoQ-21.2%

Lemonade, Inc. reported -$43.4M in net income in Q2 2026. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is down 21.2%.

EPS (Diluted)

-$0.56

YoY+6.7%

QoQ-19.1%

Lemonade, Inc. earned -$0.56 per diluted share (EPS) in Q2 2026. This represents an increase of 6.7% from the same quarter a year earlier. Against the prior quarter it is down 19.1%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

-$8.0M

YoY-335.3%

QoQ-95.1%

Lemonade, Inc. recorded an outflow of $8.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 335.3% from the same quarter a year earlier. Against the prior quarter it is down 95.1%.

Cash & Debt

$367.6M

YoY-2.6%

QoQ-1.8%

5Y CAGR-19.6%

Lemonade, Inc. held $367.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

77M

YoY+4.8%

QoQ+0.7%

5Y CAGR+4.7%

Lemonade, Inc. had 77M shares outstanding in Q2 2026. This represents an increase of 4.8% from the same quarter a year earlier. Against the prior quarter it is up 0.7%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

-14.7%

YoY+12.0pp

QoQ-0.9pp

Lemonade, Inc.'s net profit margin was -14.7% in Q2 2026, showing the share of revenue converted to profit. This is up 12.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Return on Equity

-8.7%

YoY-0.4pp

QoQ-1.8pp

5Y change-3.6pp

Lemonade, Inc.'s ROE was -8.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$30.0M

YoY+33.9%

QoQ+11.5%

5Y CAGR+16.5%

Lemonade, Inc. invested $30.0M in research and development in Q2 2026. This represents an increase of 33.9% from the same quarter a year earlier. Against the prior quarter it is up 11.5%.

Capital Expenditures

$4.6M

YoY+119.0%

QoQ+31.4%

5Y CAGR+11.2%

Lemonade, Inc. invested $4.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 119.0% from the same quarter a year earlier. Against the prior quarter it is up 31.4%.

Share Buybacks

Not reported for Q2 2026.

LMND Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LMND quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Revenue	$975.0M	$737.9M+40.2%	$526.5M+22.5%	$429.8M+67.4%	$256.7M+99.9%	$128.4M+36.0%	$94.4M+40.3%	$67.3M+199.1%	$22.5M
R&D Expenses	$106.4M	$93.9M+9.4%	$85.8M-3.4%	$88.8M+11.6%	$79.6M+53.7%	$51.8M+167.0%	$19.4M+98.0%	$9.8M+108.5%	$4.7M
SG&A Expenses	$168.1M	$139.8M+12.3%	$124.5M-3.7%	$129.3M+5.7%	$122.3M+68.5%	$72.6M+56.8%	$46.3M+115.3%	$21.5M+131.2%	$9.3M
Income Tax	$5.1M	$4.6M+370.6%	-$1.7M-123.9%	$7.1M+136.7%	$3.0M-61.0%	$7.7M+413.3%	$1.5M+150.0%	$600K+100.0%	$300K
Net Income	-$138.9M	-$166.0M+17.9%	-$202.2M+14.6%	-$236.9M+20.4%	-$297.8M-23.4%	-$241.3M-97.3%	-$122.3M-12.7%	-$108.5M-105.1%	-$52.9M
EPS (Basic)	N/A	-$2.24+21.4%	-$2.85+16.2%	-$3.40+25.9%	-$4.59-16.5%	-$3.94-8.5%	-$3.63+62.8%	-$9.75	N/A
EPS (Diluted)	-$1.82	-$2.24+21.4%	-$2.85+16.2%	-$3.40+25.9%	-$4.59-16.5%	-$3.94	-$3.63	-$9.75	N/A
Diluted Shares (Avg)	N/A	74M+4.1%	71M+2.0%	70M+7.3%	65M+6.0%	61M	34M	11M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$294.4M+79.4%	$258.0M+70.6%	$228.1M+53.3%	$194.5M+42.4%	$164.1M+34.5%	$151.2M+27.0%	$148.8M+28.8%	$136.6M+19.3%
R&D Expenses	$30.0M+33.9%	$26.9M+22.3%	$24.8M+13.8%	$24.7M+12.8%	$22.4M+5.7%	$22.0M+5.3%	$21.8M+3.3%	$21.9M+0.5%
SG&A Expenses	$47.8M+85.3%	$42.2M+17.5%	$43.1M+28.7%	$35.0M+11.5%	$25.8M-13.4%	$35.9M+20.5%	$33.5M+15.5%	$31.4M-14.9%
Income Tax	$1.6M+23.1%	$1.2M+20.0%	$1.1M+114.1%	$1.2M-36.8%	$1.3M-38.1%	$1.0M-52.4%	-$7.8M-378.6%	$1.9M0.0%
Net Income	-$43.4M+1.1%	-$35.8M+42.6%	-$22.2M+26.0%	-$37.5M+44.6%	-$43.9M+23.3%	-$62.4M-31.9%	-$30.0M+29.2%	-$67.7M-10.1%
EPS (Basic)	-$0.56+6.7%	-$0.47+45.3%	-$0.28+31.7%	-$0.51+46.3%	-$0.60+25.9%	-$0.86-28.4%	-$0.41+31.7%	-$0.95-8.0%
EPS (Diluted)	-$0.56+6.7%	-$0.47+45.3%	-$0.28+31.7%	-$0.51+46.3%	-$0.60+25.9%	-$0.86-28.4%	-$0.41+31.7%	-$0.95-8.0%
Diluted Shares (Avg)	77M+4.8%	76M+4.6%	N/A	74M+4.3%	73M+3.8%	73M+3.8%	N/A	71M+2.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Operating Income, EBITDA, Interest Expense.

LMND Balance Sheet

LMND quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Total Assets	$1.9B+4.1%	$1.8B+13.2%	$1.6B-3.4%	$1.7B+11.9%	$1.5B+82.3%	$828.7M+100.0%	$414.3M	N/A
Cash & Equivalents	$385.0M+2.4%	$376.0M+42.2%	$264.5M-6.4%	$282.5M+4.4%	$270.6M-52.6%	$570.8M+111.4%	$270.0M+163.7%	$102.4M
Short-Term Investments	$14.1M-48.7%	$27.5M-40.0%	$45.8M-54.1%	$99.8M-9.6%	$110.4M	$0-100.0%	$54.7M	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M	$0	N/A	N/A	N/A
Total Liabilities	$1.4B+10.9%	$1.3B+35.8%	$924.4M+12.2%	$823.9M+57.7%	$522.3M+81.5%	$287.7M-51.8%	$596.8M	N/A
Total Equity	$533.6M-10.1%	$593.4M-16.3%	$708.9M-18.2%	$866.8M-12.3%	$988.2M+82.7%	$541.0M+396.4%	-$182.5M-130.7%	-$79.1M
Retained Earnings	-$1.5B-12.7%	-$1.3B-18.4%	-$1.1B-27.6%	-$859.7M-53.0%	-$561.9M-75.3%	-$320.6M-61.7%	-$198.3M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.0B+4.0%	$2.0B+5.5%	$1.9B+4.1%	$1.9B+5.3%	$1.9B+12.9%	$1.9B+12.8%	$1.8B+13.2%	$1.8B+10.6%
Cash & Equivalents	$367.6M-2.6%	$374.3M+21.1%	$385.0M+2.4%	$345.9M+4.9%	$377.5M+10.0%	$309.2M+10.9%	$376.0M+42.2%	$329.8M+42.3%
Short-Term Investments	$9.2M-56.8%	$19.5M-4.9%	$14.1M-48.7%	$23.5M-24.4%	$21.3M-51.6%	$20.5M-7.2%	$27.5M-40.0%	$31.1M-57.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%
Total Liabilities	$1.5B+7.5%	$1.4B+9.8%	$1.4B+10.9%	$1.4B+14.0%	$1.4B+30.5%	$1.3B+35.2%	$1.3B+35.8%	$1.2B+33.6%
Total Equity	$499.5M-5.2%	$518.0M-5.0%	$533.6M-10.1%	$516.2M-13.0%	$527.1M-17.0%	$545.5M-19.4%	$593.4M-16.3%	$593.0M-18.4%
Retained Earnings	-$1.5B-9.8%	-$1.5B-10.2%	-$1.5B-12.7%	-$1.4B-13.7%	-$1.4B-17.0%	-$1.4B-19.0%	-$1.3B-18.4%	-$1.3B-20.4%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

LMND Cash Flow Statement

LMND quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Operating Cash Flow	$21.2M	-$16.5M-44.7%	-$11.4M+90.4%	-$119.1M+26.9%	-$163.0M-12.7%	-$144.6M-57.7%	-$91.7M-17.4%	-$78.1M-91.4%	-$40.8M
Depreciation & Amortization	N/A	$15.2M-24.0%	$20.0M0.0%	$20.0M+63.9%	$12.2M+229.7%	$3.7M+117.6%	$1.7M+183.3%	$600K+500.0%	$100K
Stock-Based Compensation	N/A	$61.3M-5.0%	$64.5M+7.7%	$59.9M+1.0%	$59.3M+34.5%	$44.1M+316.0%	$10.6M+146.5%	$4.3M+104.8%	$2.1M
Capital Expenditures	$13.1M	$9.4M0.0%	$9.4M+2.2%	$9.2M-8.9%	$10.1M+7.4%	$9.4M+113.6%	$4.4M+63.0%	$2.7M+285.7%	$700K
Free Cash Flow	$8.1M	-$25.9M-24.5%	-$20.8M+83.8%	-$128.3M+25.9%	-$173.1M-12.4%	-$154.0M-60.2%	-$96.1M-18.9%	-$80.8M-94.7%	-$41.5M
Investing Cash Flow	-$145.1M	-$89.1M-319.5%	$40.6M-54.2%	$88.7M-51.0%	$181.1M+122.5%	-$804.8M-1706.4%	$50.1M+192.8%	-$54.0M-943.8%	$6.4M
Financing Cash Flow	$116.9M	$106.6M+21.6%	$87.7M+469.5%	$15.4M+327.8%	$3.6M-99.4%	$649.6M+90.4%	$341.1M+13.7%	$300.1M+150.3%	$119.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$3.4M-161.8%	-$600K+98.7%	$20.7M+50.0%	$4.5M-72.4%	$5.5M+147.0%	-$47.2M-58.4%	$13.8M+185.7%	$16.3M+358.7%
Depreciation & Amortization	$2.4M-48.9%	$2.7M-40.0%	$2.6M-44.7%	$3.4M-33.3%	$4.7M-9.6%	$4.5M-10.0%	$4.7M-2.1%	$5.1M+2.0%
Stock-Based Compensation	$24.5M+59.1%	$21.2M+105.8%	N/A	$17.1M+1.2%	$15.4M0.0%	$10.3M-30.9%	N/A	$16.9M+9.7%
Capital Expenditures	$4.6M+119.0%	$3.5M+52.2%	$3.1M-3.1%	$1.9M-13.6%	$2.1M+40.0%	$2.3M-8.0%	$3.2M+33.3%	$2.2M0.0%
Free Cash Flow	-$8.0M-335.3%	-$4.1M+91.7%	$17.6M+66.0%	$2.6M-81.6%	$3.4M+125.8%	-$49.5M-53.3%	$10.6M+157.3%	$14.1M+265.9%
Investing Cash Flow	-$32.2M-209.2%	-$34.6M+14.1%	-$18.9M-856.0%	-$59.4M-9.8%	$29.5M-51.9%	-$40.3M-230.4%	$2.5M-93.8%	-$54.1M-223.8%
Financing Cash Flow	$28.2M+17.0%	$26.2M+31.0%	$38.5M+10.0%	$24.0M+1.7%	$24.1M+54.5%	$20.0M+48.1%	$35.0M+386.1%	$23.6M+198.7%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

LMND Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LMND quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Net Margin	-22.5%+15.9pp	-38.4%+16.7pp	-55.1%	-116.0%	-187.9%	-129.6%	-161.2%	-235.1%
Return on Equity	-31.1%+3.0pp	-34.1%-0.7pp	-33.4%+0.9pp	-34.4%-9.9pp	-24.4%-1.8pp	-22.6%	N/A	N/A
Return on Assets	-8.6%+2.3pp	-10.9%+3.6pp	-14.5%+3.1pp	-17.6%-1.6pp	-16.0%-1.2pp	-14.8%+11.4pp	-26.2%	N/A
Debt-to-Equity	2.61+0.5x	2.12+0.8x	1.30+0.4x	0.95+0.4x	0.530.0x	0.53	N/A	N/A
Asset Turnover	0.38+0.1x	0.280.0x	0.26+0.1x	0.15+0.1x	0.090.0x	0.110.0x	0.16	N/A
FCF Margin	-3.5%+0.4pp	-4.0%+25.9pp	-29.8%+37.6pp	-67.4%	-119.9%	-101.8%	-120.1%	-184.4%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	-14.7%+12.0pp	-13.9%+27.4pp	-9.7%+10.4pp	-19.3%+30.3pp	-26.8%+20.1pp	-41.3%-1.6pp	-20.2%+16.5pp	-49.6%+4.2pp
Return on Equity	-8.7%-0.4pp	-6.9%+4.5pp	-4.2%+0.9pp	-7.3%+4.2pp	-8.3%+0.7pp	-11.4%-4.5pp	-5.1%+0.9pp	-11.4%-3.0pp
Return on Assets	-2.2%+0.1pp	-1.8%+1.5pp	-1.1%+0.5pp	-1.9%+1.8pp	-2.3%+1.1pp	-3.4%-0.5pp	-1.6%+1.0pp	-3.7%0.0pp
Debt-to-Equity	3.03+0.4x	2.78+0.4x	2.61+0.5x	2.72+0.6x	2.67+1.0x	2.40+1.0x	2.12+0.8x	2.07+0.8x
Asset Turnover	0.15+0.1x	0.13+0.1x	0.120.0x	0.100.0x	0.080.0x	0.080.0x	0.080.0x	0.070.0x
FCF Margin	-2.7%-4.8pp	-1.6%+31.1pp	7.7%+0.6pp	1.3%-9.0pp	2.1%+12.9pp	-32.7%-5.6pp	7.1%+23.1pp	10.3%+17.7pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Lemonade, Inc. LMND	FY2025	$737.9M	-$166.0M	-22.5%	$3.6B	48/100
Mercury General Corp. MCY	FY2025	$6.0B	$541.1M	9.0%	$5.7B	34/100
Kemper Corporation KMPR	FY2025	$4.8B	$143.3M	3.0%	$1.6B	8/100
Palomar Holdings, Inc. PLMR	FY2025	$876.0M	$197.1M	22.5%	$3.4B	67/100
Selective Insurance Group SIGI	FY2025	$5.3B	$466.4M	8.7%	$5.0B	43/100
Hagerty, Inc. HGTY	FY2025	$1.5B	$149.2M	10.3%	$1.6B	37/100

Where Lemonade, Inc. Ranks

Frequently Asked Questions

What is Lemonade, Inc.'s annual revenue?

Lemonade, Inc. (LMND) reported $737.9M in total revenue for fiscal year 2025. This represents a 40.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lemonade, Inc.'s revenue growing?

Lemonade, Inc. (LMND) revenue grew by 40.2% year-over-year, from $526.5M to $737.9M in fiscal year 2025.

Is Lemonade, Inc. profitable?

No, Lemonade, Inc. (LMND) reported a net income of -$166.0M in fiscal year 2025, with a net profit margin of -22.5%.

What is Lemonade, Inc.'s net profit margin?

Lemonade, Inc. (LMND) had a net profit margin of -22.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Lemonade, Inc.'s return on equity (ROE)?

Lemonade, Inc. (LMND) has a return on equity of -31.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lemonade, Inc.'s free cash flow?

Lemonade, Inc. (LMND) recorded an outflow of $25.9M in free cash flow during fiscal year 2025. This represents a -24.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lemonade, Inc.'s operating cash flow?

Lemonade, Inc. (LMND) recorded an outflow of $16.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Lemonade, Inc.'s total assets?

Lemonade, Inc. (LMND) had $1.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lemonade, Inc.'s capital expenditures?

Lemonade, Inc. (LMND) invested $9.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Lemonade, Inc. spend on research and development?

Lemonade, Inc. (LMND) invested $93.9M in research and development during fiscal year 2025.

How many shares does Lemonade, Inc. have outstanding?

Lemonade, Inc. (LMND) had 76M shares outstanding as of fiscal year 2025.

What is Lemonade, Inc.'s debt-to-equity ratio?

Lemonade, Inc. (LMND) had a debt-to-equity ratio of 2.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lemonade, Inc.'s return on assets (ROA)?

Lemonade, Inc. (LMND) had a return on assets of -8.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lemonade, Inc.'s P/E ratio?

Lemonade, Inc. (LMND) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $3.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lemonade, Inc.'s price-to-sales ratio?

Lemonade, Inc. (LMND) trades at 3.7x sales, its market capitalization divided by revenue of $975.0M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lemonade, Inc.'s Piotroski F-Score?

Lemonade, Inc. (LMND) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lemonade, Inc.'s earnings high quality?

Lemonade, Inc. (LMND) reported a net loss of $166.0M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Lemonade, Inc.?

Lemonade, Inc. (LMND) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.